Immucor to Buy BioArray Solutions for $117M To Grow Transfusion, Transplantation Reach

The company envisions making BioArray Solutions’ platform the central piece of an automated system that will eventually succeed Immucor’s current blood-screening platform, the Galileo.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.